HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation.

Abstract
Neuroferritinopathy is a progressive potentially treatable adult-onset movement disorder caused by mutations in the ferritin light chain gene (FTL1). Features overlap with common extrapyramidal disorders: idiopathic torsion dystonia, idiopathic Parkinson's disease and Huntington's disease, but the phenotype and natural history have not been defined. We studied a genetically homogeneous group of 41 subjects with the 460InsA mutation in FTL1, documenting the presentation, clinical course, biochemistry and neuroimaging. The mean age of onset was 39.4 years (SD = 13.3, range 13-63), beginning with chorea in 50%, focal lower limb dystonia in 42.5% and parkinsonism in 7.5%. The majority reported a family history of a movement disorder often misdiagnosed as Huntington's disease. The disease progressed relentlessly, becoming generalized over a 5-10 year period, eventually leading to aphonia, dysphagia and severe motor disability with subcortical/frontal cognitive dysfunction as a late feature. A characteristic action-specific facial dystonia was common (65%), and in 63% there was asymmetry throughout the disease course. Serum ferritin levels were low in the majority of males and post-menopausal females, but within normal limits for pre-menopausal females. MR brain imaging was abnormal on all affected individuals and one presymptomatic carrier. In conclusion, isolated parkinsonism is unusual in neuroferritinopathy, and unlike Huntington's disease, cognitive changes are absent or subtle in the early stages. Depressed serum ferritin is common and provides a useful screening test in routine practice, and gradient echo brain MRI will identify all symptomatic cases.
AuthorsPatrick F Chinnery, Douglas E Crompton, Daniel Birchall, Margaret J Jackson, Alan Coulthard, Anne Lombès, Niall Quinn, Adrian Wills, Nicholas Fletcher, John P Mottershead, Paul Cooper, Mark Kellett, David Bates, John Burn
JournalBrain : a journal of neurology (Brain) Vol. 130 Issue Pt 1 Pg. 110-9 (Jan 2007) ISSN: 1460-2156 [Electronic] England
PMID17142829 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ferritins
  • Apoferritins
Topics
  • Adolescent
  • Adult
  • Age of Onset
  • Apoferritins (genetics)
  • Brain (pathology)
  • Chorea (genetics, metabolism, pathology)
  • Dystonia (genetics, metabolism, pathology)
  • Family Health
  • Female
  • Ferritins (blood)
  • Humans
  • Magnetic Resonance Imaging (methods)
  • Male
  • Middle Aged
  • Movement Disorders (genetics, metabolism, pathology)
  • Muscle, Skeletal (pathology)
  • Mutation (genetics)
  • Parkinson Disease (genetics, metabolism, pathology)
  • Phenotype
  • Sex Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: